Suppr超能文献

用于检测临床样本中乙型肝炎病毒基因型和诊断逃逸变异体的HBsAg定量检测方法的性能

Performance of HBsAg quantification assays for detection of Hepatitis B virus genotypes and diagnostic escape-variants in clinical samples.

作者信息

Thibault Vincent, Servant-Delmas Annabelle, Ly Thoai Duong, Roque-Afonso Anne-Marie, Laperche Syria

机构信息

Laboratoire de Virologie, GH Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.

Institut National de la Transfusion Sanguine (INTS), Département d'études des Agents Transmissibles par le Sang, Centre national de référence des hépatites virales B et C et du VIH en Transfusion, 6 rue Alexandre Cabanel, F-75015 Paris, France.

出版信息

J Clin Virol. 2017 Apr;89:14-21. doi: 10.1016/j.jcv.2017.02.001. Epub 2017 Feb 4.

Abstract

BACKGROUND

The impact of hepatitis B virus (HBV) genomic variability on the measurement of HBsAg level has been poorly evaluated.

OBJECTIVE

This study was designed to compare the performance of all the available assays measuring HBsAg level in this setting.

STUDY DESIGN

A large selection of wild type HBV genotypes (n=184) and HBsAg strains harboring mutations in the S gene (n=81) from clinical samples was studied with three HBsAg quantification assays: Architect HBsAg (Abbott), LiaisonXL Murex HBsAg Quant (DiaSorin) and the Elecsys HBsAgII (Roche).

RESULTS

The overall percentage of positive results was 99.2% for Abbott, 98.9% for DiaSorin and 98.1% for Roche. Abbott and Roche assays provided an excellent concordance in HBsAg quantification (global mean bias of -0.006 logIU/mL). By contrast, DiaSorin underestimated HBsAg level with values 0.112 logIU/ml and 0.103 logIU/ml lower than Abbott and Roche, respectively. By contrast, DiaSorin slightly over quantified gtC (2.5% over the expected value) while Abbott provided values 6.2% lower than expected and 16.2% lower than what observed for the other genotypes. HBsAg quantitative assays were influenced by HBs protein substitutions irrespective to the genotype but no specific protein pattern that would particularly impair the quantification by one technique has been identified. However, Roche seemed to be particularly impacted by substitutions at 145 residue: 75% of under quantified samples carried a substituted 145 residue.

CONCLUSION

This head-to-head comparison indicates a good correlation between all current systems used to quantify HBsAg but clearly shows an influence of both the genotype and the presence of "a" determinant variants in the absolute quantification of HBsAg. While these discrepancies may not translate into major clinical consequence, they may explain an absence of detection of weak concentration of HBsAg on some systems.

摘要

背景

乙型肝炎病毒(HBV)基因组变异性对HBsAg水平测量的影响尚未得到充分评估。

目的

本研究旨在比较在此情况下所有可用的HBsAg水平检测方法的性能。

研究设计

使用三种HBsAg定量检测方法对大量从临床样本中选取的野生型HBV基因型(n = 184)和S基因中存在突变的HBsAg毒株(n = 81)进行研究:Architect HBsAg(雅培)、LiaisonXL Murex HBsAg Quant(索灵)和Elecsys HBsAgII(罗氏)。

结果

雅培的阳性结果总体百分比为99.2%,索灵为98.9%,罗氏为98.1%。雅培和罗氏检测方法在HBsAg定量方面具有良好的一致性(总体平均偏差为 -0.006 logIU/mL)。相比之下,索灵低估了HBsAg水平,其值分别比雅培和罗氏低0.112 logIU/ml和0.103 logIU/ml。相比之下,索灵对gtC的定量略有高估(比预期值高2.5%),而雅培提供的值比预期低6.2%,比其他基因型观察到的值低16.2%。HBsAg定量检测受HBs蛋白替代的影响,与基因型无关,但尚未发现会特别损害一种技术定量的特定蛋白模式。然而,罗氏似乎特别受145位残基替代的影响:75%定量不足的样本携带145位残基替代。

结论

这种直接比较表明,目前用于定量HBsAg的所有系统之间具有良好的相关性,但清楚地表明基因型和“a”决定簇变体的存在对HBsAg的绝对定量有影响。虽然这些差异可能不会转化为重大临床后果,但它们可能解释了在某些系统上未检测到低浓度HBsAg的原因。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验